BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $20,715,000 | -32.3% | 213,050 | -21.9% | 0.06% | -26.2% |
| Q4 2020 | $30,581,000 | -76.9% | 272,681 | -80.9% | 0.08% | -82.5% |
| Q3 2020 | $132,632,000 | +4.3% | 1,430,767 | -12.2% | 0.48% | -12.8% |
| Q2 2020 | $127,118,000 | +35.8% | 1,629,716 | +1.8% | 0.55% | +12.7% |
| Q1 2020 | $93,595,000 | -10.6% | 1,600,467 | +22.5% | 0.49% | -0.6% |
| Q4 2019 | $104,667,000 | +77.7% | 1,306,541 | +63.0% | 0.49% | +59.6% |
| Q3 2019 | $58,896,000 | +13.3% | 801,639 | +45.5% | 0.31% | +31.8% |
| Q2 2019 | $51,980,000 | -1.4% | 551,040 | -16.3% | 0.23% | -22.8% |
| Q1 2019 | $52,726,000 | -18.5% | 658,661 | -45.1% | 0.30% | -17.9% |
| Q4 2018 | $64,709,000 | +646.2% | 1,200,322 | +980.4% | 0.37% | +666.7% |
| Q3 2018 | $8,672,000 | – | 111,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |